ALK-Abelló A/S
General ticker "AKBLF" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $5.7B (TTM average)
ALK-Abelló A/S follows the US Stock Market performance with the rate: 41.4%.
Estimated limits based on current volatility of 0.2%: low 36.11$, high 36.27$
Short-term AKBLF quotes
Long-term AKBLF plot
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | DKK4,511.00MM | DKK4,824.00MM | DKK5,537.00MM |
| Operating Expenses | DKK4,041.00MM | DKK4,158.00MM | DKK4,446.00MM |
| Operating Income | DKK470.00MM | DKK666.00MM | DKK1,091.00MM |
| Non-Operating Income | DKK-23.00MM | DKK-19.00MM | DKK-34.00MM |
| Interest Expense | DKK24.00MM | DKK22.00MM | DKK65.00MM |
| R&D Expense | DKK665.00MM | DKK618.00MM | DKK531.00MM |
| Income(Loss) | DKK447.00MM | DKK647.00MM | DKK1,057.00MM |
| Taxes | DKK112.00MM | DKK161.00MM | DKK242.00MM |
| Profit(Loss)* | DKK335.00MM | DKK486.00MM | DKK815.00MM |
| Stockholders Equity | DKK3,988.00MM | DKK4,447.00MM | DKK5,373.00MM |
| Inventory | DKK1,297.00MM | DKK1,423.00MM | DKK1,716.00MM |
| Assets | DKK6,308.00MM | DKK6,726.00MM | DKK8,246.00MM |
| Operating Cash Flow | DKK416.00MM | DKK667.00MM | DKK1,213.00MM |
| Capital expenditure | DKK298.00MM | DKK379.00MM | DKK1,303.00MM |
| Investing Cash Flow | DKK-351.00MM | DKK-375.00MM | DKK-1,417.00MM |
| Financing Cash Flow | DKK-42.00MM | DKK-31.00MM | DKK310.00MM |
| Earnings Per Share** | DKK1.52 | DKK2.20 | DKK3.68 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.